Facebook PixelCan we foresee pharmaceutical markets dominated by biosimilars in future?
Brainstorming
Brainstorming
Create newCreate new
EverythingEverything
Sessions onlySessions only
Ideas onlyIdeas only
Brainstorming session

Can we foresee pharmaceutical markets dominated by biosimilars in future?

Image credit: https://consultqd.clevelandclinic.org/generics-and-biosimilars-in-multiple-sclerosis-navigating-a-new-therapy-landscape/

Loading...
KB
Kritika Bansal Nov 12, 2020

[1]Konstantinidou, S., Papaspiliou, A., Kokkotou, E."Current and future roles of biosimilars in oncology practice (Review)". Oncology Letters 19.1 (2020): 45-51.

[2]Kim, HoUng et al. “The Future of Biosimilars: Maximizing Benefits Across Immune-Mediated Inflammatory Diseases.” Drugs vol. 80,2 (2020): 99-113. doi:10.1007/s40265-020-01256-5

3
Creative contributions

Questions first: But why are they different if they have the same clinical properties?

Loading...
Subash Chapagain
Subash Chapagain Nov 13, 2020

no easy entry, as everything new

Loading...
Martina Pesce
Martina Pesce Nov 13, 2020

[1]Biosimilars: what clinicians should know. 2012, 120 (26):5111-7 Blood

I imagine a bit of patients resistance

Loading...
Martina Pesce
Martina Pesce Nov 13, 2020

[1][1] E. Dubé, M. Vivion, and N. E. MacDonald, “Vaccine hesitancy, vaccine refusal and the anti-vaccine movement: Influence, impact and implications,” Expert Review of Vaccines. 2014.

Add your creative contribution

0 / 200

Added via the text editor

Sign up or

or

Guest sign up

* Indicates a required field

By using this platform you agree to our terms of service and privacy policy.

General comments